If you have eczema, you know it’s more than a rash.

Research studies are enrolling now.

Those who qualify may receive*:

  • Payment up to $600, which varies by study
  • Study-related care at no cost from local doctors
  • Study medication at no cost

Plus, no cost to you.
No health insurance or referral needed.

Ready to get started? Click Here.

Eczema, also known as atopic dermatitis is not just a cosmetic disease.

  • Eczema is a chronic skin condition that causes patches of red, itchy, dry skin to appear on various parts of the body.
  • Moderate or severe eczema can cause intense pain, itchiness, and skin cracking. Eczema can flare periodically, especially when exposed to certain triggers such as cold or dry air and contact with irritants, including rough fabrics and chemicals such as perfumes or dyes.
  • Moderate to severe eczema can interfere with everyday life, causing absences at work days and missed social activities. And, eczema patches on visible areas of the body, such as the face, neck, and hands may cause embarrassment.

Current treatments for eczema do not work well for everyone. That’s why local doctors are conducting research studies and evaluating study medications that are not available from regular doctors.

Take the next step to see if you qualify for local research studies for people with Eczema. But don’t delay — space is limited!

* In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. For studies that offer compensation, reasonable payments will be made for participation. The length of the study may vary.

Ready to get started?

Click Here.

How does it work?


Tell us a little bit about yourself


Answer some questions about your health


We will connect you to available studies in your area

Just takes a few minutes


AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.